Welcome to the CIRM Genomics Hub, created from the Genomics Initiative from the California Institute for Regenerative Medicine's Center of Excellence for Stem Cell Genomics (CESCG).
The CESCG is made up of approximately 20 separate projects, all involving stem or progenitor cells. The first release of information explores single cell expression datasets in the human brain, tools to deconvolute complex mixtures of brain cells into cell types and developmental states, and scorecards for in vitro differentiation into brain subclasses.
Oct 23, 2017 - CIRM blog post about tools developed through the Genomics Initiative! Read more
That's all! Come back later for information on dataset releases, new features, and other announcements from the the CESCG Stem Cell Hub.
Created in 2014 through a $40 million award by California's stem cell agency, the California Institute for Regenerative Medicine (CIRM), the Center of Excellence in Stem Cell Genomics (CESCG) is spearheading the investigation into how stem cells can be used to treat disease.
This Center merges the genomics expertise of the Stanford University research team under the seasoned leadership of Mike Snyder, with the cutting edge expertise of the Salk Institute and University of California, San Diego groups in epigenomics, led by Joseph Ecker. These two leaders in the field of genomics have extensive experience working on large-scale projects and have been working in national and international consortia for generating and distributing genomics data. This Center of Excellence also includes the experience of Josh Stuart and David Haussler, leaders in data coordination and management, from the University of California, Santa Cruz (UCSC), extending collaborative relationships that have been developed over the past decade.
Our vision is to advance Stem Cell research in the State of California by establishing the Center of Excellence in Stem Cell Genomics (CESCG). The Center is generating banks of data and iPS cell lines that are valuable resources to the entire CIRM community and provide important insights into stem cell research. It also serves as an important focal point for collaborative projects with other CIRM investigators and makes genomics capabilities available to the entire regenerative medicine community.